Physician profile
Ling Li
NPI 1235207028
$3,162.61
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,414 · 2020: $1,300 · 2021: $59.66 · 2022: $75.39 · 2023: $134 · 2024: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,239.44 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $254.85 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $134.01 | 2023 | Ongentys |
| Argenx US, INC. | $102.75 | 2022-2024 | Vyvgart Hytrulo |
| Alexion Pharmaceuticals, INC. | $97.94 | 2019 | |
| Biogen, INC. | $97.75 | 2024 | Vumerity |
| Emd Serono, INC. | $96.88 | 2019 | |
| Lilly USA, LLC | $83.85 | 2020 | |
| Acadia Pharmaceuticals INC | $20.32 | 2022 | |
| Pfizer INC. | $17.64 | 2024 | |
| Abbvie INC. | $17.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ling Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.